Famciclovir fundamentals
When pharmacists should and shouldn't prescribe famciclovir as a Schedule 3 antiviral treatment for cold sores.
Tirzepatide users on oral contraceptives face pregnancy risk
New advice from the Therapeutic Guidelines highlights that tirzepatide could interfere with the efficacy of oral contraceptives.
Active Ingredient Prescribing grace period comes to an end
A new wave of private prescriptions may be approaching, as the Active Ingredient Prescribing (AIP) grace period comes to an end.
Small towns, big challenges
With the launch of a new PSA report, pharmacists in regional and remote areas highlight disadvantages that access to more funding, collaboration and medication management reviews could improve.
Top tips for becoming a sought-after GP pharmacist
With many GPs seeing the value of multidisciplinary care teams including pharmacists, here's how to become a GP pharmacist.
Montelukast use sparks suicide concerns
With reports of children as young as 5 attempting suicide and low efficacy, here’s how pharmacists can approach montelukast supply.













